These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8489325)

  • 1. Brain morphology, dopamine, and eye-tracking abnormalities in first-episode schizophrenia. Prevalence and clinical correlates.
    Lieberman JA; Jody D; Alvir JM; Ashtari M; Levy DL; Bogerts B; Degreef G; Mayerhoff DI; Cooper T
    Arch Gen Psychiatry; 1993 May; 50(5):357-68. PubMed ID: 8489325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time course and biologic correlates of treatment response in first-episode schizophrenia.
    Lieberman J; Jody D; Geisler S; Alvir J; Loebel A; Szymanski S; Woerner M; Borenstein M
    Arch Gen Psychiatry; 1993 May; 50(5):369-76. PubMed ID: 8098203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of psychobiology in first-episode schizophrenia at Hillside Hospital.
    Lieberman JA; Alvir JM; Woerner M; Degreef G; Bilder RM; Ashtari M; Bogerts B; Mayerhoff DI; Geisler SH; Loebel A
    Schizophr Bull; 1992; 18(3):351-71. PubMed ID: 1411327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of clinical symptoms to apomorphine-stimulated growth hormone release in mood-incongruent psychotic patients.
    Zemlan FP; Hirschowitz J; Garver DL
    Arch Gen Psychiatry; 1986 Dec; 43(12):1162-7. PubMed ID: 3778112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal eye tracking is associated with abnormal morphology of medial temporal lobe structures in schizophrenia.
    Levy DL; Bogerts B; Degreef G; Dorogusker B; Waternaux C; Ashtari M; Jody D; Geisler S; Lieberman JA
    Schizophr Res; 1992 Oct; 8(1):1-10. PubMed ID: 1419933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
    Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
    Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of psychotic symptom clusters in schizophrenia to neuroleptic treatment and growth hormone response to apomorphine.
    Zemlan FP; Hirschowitz J; Sautter F; Garver DL
    Psychiatry Res; 1986 Jul; 18(3):239-55. PubMed ID: 2875478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schneider's first-rank symptoms of schizophrenia. An association with increased growth hormone response to apomorphine.
    Whalley LJ; Christie JE; Brown S; Arbuthnott GW
    Arch Gen Psychiatry; 1984 Nov; 41(11):1040-3. PubMed ID: 6497565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder.
    Robinson DG; Woerner MG; Alvir JM; Geisler S; Koreen A; Sheitman B; Chakos M; Mayerhoff D; Bilder R; Goldman R; Lieberman JA
    Am J Psychiatry; 1999 Apr; 156(4):544-9. PubMed ID: 10200732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. White matter abnormalities in first-episode schizophrenia or schizoaffective disorder: a diffusion tensor imaging study.
    Szeszko PR; Ardekani BA; Ashtari M; Kumra S; Robinson DG; Sevy S; Gunduz-Bruce H; Malhotra AK; Kane JM; Bilder RM; Lim KO
    Am J Psychiatry; 2005 Mar; 162(3):602-5. PubMed ID: 15741480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noradrenergic and dopaminergic interrelation in schizophrenia.
    Brambilla F; Marini S; Saito A; Fassone G; Picardi A; Nerozzi D; Pancheri P
    Psychiatry Res; 1994 Sep; 53(3):231-42. PubMed ID: 7870845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subjective cognitive dysfunction, eye tracking, and slow brain potentials in schizophrenic and schizoaffective patients.
    van den Bosch RJ; Rozendaal N
    Biol Psychiatry; 1988 Nov; 24(7):741-6. PubMed ID: 3228564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylphenidate increases thought disorder in recent onset schizophrenics, but not in normal controls.
    Levy DL; Smith M; Robinson D; Jody D; Lerner G; Alvir J; Geisler SH; Szymanski SR; Gonzalez A; Mayerhoff DI
    Biol Psychiatry; 1993 Oct; 34(8):507-14. PubMed ID: 8274577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medial temporal lobe structures and hippocampal subfields in psychotic disorders: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study.
    Mathew I; Gardin TM; Tandon N; Eack S; Francis AN; Seidman LJ; Clementz B; Pearlson GD; Sweeney JA; Tamminga CA; Keshavan MS
    JAMA Psychiatry; 2014 Jul; 71(7):769-77. PubMed ID: 24828364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral response to methylphenidate and treatment outcome in first episode schizophrenia.
    Jody D; Lieberman JA; Geisler S; Szymanski S; Alvir JM
    Psychopharmacol Bull; 1990; 26(2):224-30. PubMed ID: 2236460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of outcome in first-episode schizophrenia.
    Lieberman JA
    J Clin Psychiatry; 1993 Mar; 54 Suppl():13-7. PubMed ID: 8097192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of cerebral deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia: an optimized voxel-based morphometry and resting state functional connectivity study.
    Lui S; Deng W; Huang X; Jiang L; Ma X; Chen H; Zhang T; Li X; Li D; Zou L; Tang H; Zhou XJ; Mechelli A; Collier DA; Sweeney JA; Li T; Gong Q
    Am J Psychiatry; 2009 Feb; 166(2):196-205. PubMed ID: 18981063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lateral ventricle differences between first-episode schizophrenia and first-episode psychotic bipolar disorder: A population-based morphometric MRI study.
    Rosa PG; Schaufelberger MS; Uchida RR; Duran FL; Lappin JM; Menezes PR; Scazufca M; McGuire PK; Murray RM; Busatto GF
    World J Biol Psychiatry; 2010 Oct; 11(7):873-87. PubMed ID: 20545464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients.
    Szymanski S; Lieberman JA; Alvir JM; Mayerhoff D; Loebel A; Geisler S; Chakos M; Koreen A; Jody D; Kane J
    Am J Psychiatry; 1995 May; 152(5):698-703. PubMed ID: 7726309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive brain changes in children and adolescents with first-episode psychosis.
    Arango C; Rapado-Castro M; Reig S; Castro-Fornieles J; González-Pinto A; Otero S; Baeza I; Moreno C; Graell M; Janssen J; Parellada M; Moreno D; Bargalló N; Desco M
    Arch Gen Psychiatry; 2012 Jan; 69(1):16-26. PubMed ID: 22213785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.